Recombinant HEV ORF3 Protein (aa 92-123) (VAng-Lsx0233)
Recombinant Hepatitis E Virus (HEV) ORF3 antigen (aa 92-123) is 3KDa, and reacts strongly with human HEV positive serum, also with Beta-galactosidase (114kDa) fused at the N-terminus. It was expressed in E. coli.
Datasheet
Specifications
Source
Human
Target
Hepatitis E Virus
Type
Viral Antigens
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
8M Urea, 20mM Tris-HCl, pH 8.0 containing 10mM betmercaptoethanol.
Purity
> 95 % pure.
Storage
Store at 2 °C to 8 °C short term, -20 °C long term.
Antigen Information
Introduction
The hepatitis E virus (HEV), is the causative agent of hepatitis E. HEV is a small, non-enveloped, positive-sense single-stranded RNA virus with an icosahedral capsid. The global burden of infections from the two major genotypes (1 and 2) is estimated at 20 million per year, leading to 70,000 deaths and 3,000 stillbirths. HEV is the major cause of sporadic hepatitis, as well as epidemic hepatitis. Hepatitis E is an enterically transmitted infection that is typically self-limited. The HEV has a fecal-oral transmission route and can spread by the consumption of uncooked or undercooked meat or fecally contaminated water within endemic areas.
Alternative Names
HEV; HEV ORF3; pORF3; Hepatitis E Virus ORF3; Hepeviridae; Hepevirus
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
